¼¼°èÀÇ °ñ¼ö³» ÁÖÀÔ ±â±â ½ÃÀå
Intraosseous Infusion Devices
»óǰÄÚµå : 1543928
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 194 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,266,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,798,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ °ñ¼ö³» ÁÖÀÔ ±â±â ½ÃÀåÀº 2030³â±îÁö 82¾ï ´Þ·¯¿¡ µµ´Þ

2023³â¿¡ 54¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ °ñ¼ö³» ÁÖÀÔ ±â±â ½ÃÀåÀº 2023-2030³â CAGR 6.3%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 82¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ÀÚµ¿ ±â¼úÀº CAGR 7.5%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 56¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼öµ¿ ±â¼ú ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 4.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 15¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 5.8%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ °ñ¼ö³» ÁÖÀÔ ±â±â ½ÃÀåÀº 2023³â¿¡ 15¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 13¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³â CAGRÀº 5.8%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 6.1%¿Í 4.9%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ °ñ¼ö³» ÁÖÀÔ ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

°ñ¼ö³» ÁÖÀÔ ±â±â¶õ ¹«¾ùÀ̸ç, ¿Ö ±¸±Þ ÀÇ·á¿¡ ÇʼöÀûÀΰ¡?

°ñ¼ö³» ÁÖÀÔ ±â±â´Â ±âÁ¸ Á¤¸Æ³»(IV) ¾×¼¼½º°¡ ºÒ°¡´ÉÇÑ °æ¿ì¿¡ ¼ö¾×, ¾à¹° ¹× Ç÷¾× Á¦Á¦¸¦ °ñ¼ö¿¡ Á÷Á¢ Åõ¿©ÇÒ ¼ö ÀÖµµ·Ï °í¾ÈµÈ Ư¼ö ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ Àåºñ´Â ƯÈ÷ ¿Ü»ó, ½ÉÀ帶ºñ, ¼îÅ©¿Í °°Àº À§±ÞÇÑ »óȲ¿¡¼­ Á¤¸ÆÀÌ ¸·Çû°Å³ª Á¤¸Æ¿¡ Á¢±ÙÇϱ⠾î·Á¿î ´Ù¸¥ »óÅ¿¡ óÇÑ È¯Àڵ鿡°Ô Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤¸ÆÁÖÀÔÀº ½Å¼ÓÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖÀ¸¸ç È¿°úÀûÀÎ Á¤¸Æ Á¢±ÙÀ» À§ÇÑ ´ë¾ÈÀ» Á¦°øÇÏ¿© »ý¸íÀ» ±¸ÇÒ ¼ö ÀÖ´Â Ä¡·á¸¦ ½Å¼ÓÇÏ°Ô ½ÃÇàÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀåºñÀÇ »ç¿ëÀº ƯÈ÷ ÀÀ±Þ½Ç, ÁßȯÀÚ½Ç, ±º µî Áï°¢ÀûÀÎ Ç÷°ü Á¢±ÙÀÌ È¯ÀÚ °á°ú¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡´Â »óȲ¿¡¼­ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº °ñ¼ö³» ÁÖÀÔ ±â±â ½ÃÀåÀ» ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº °ñ¼ö³» ÁÖÀÔ ±â±â ½ÃÀå Çü¼º¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ƯÈ÷ ±â±âÀÇ µðÀÚÀÎ, »ç¿ë ÆíÀǼº ¹× ¾ÈÀü ±â´ÉÀÇ Çõ½ÅÀÌ Áß¿äÇÕ´Ï´Ù. Ãֽаñ³» »ðÀÔ ±â±¸´Â Á¡Á¡ ´õ ÀÚµ¿ ¶Ç´Â ¹ÝÀÚµ¿À¸·Î µµÀԵǵµ·Ï ¼³°èµÇ¾î »ðÀÔ¿¡ ÇÊ¿äÇÑ ¼÷·Ãµµ¸¦ ÁÙÀ̰í ÇÕº´Áõ À§ÇèÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â±¸µéÀº ¹Ù´Ã¿¡ Âñ¸®´Â ¼Õ»óÀ» ¹æÁöÇÏ°í °ñ¼ö ³»¿¡ ¾ÈÁ¤ÀûÀ¸·Î °íÁ¤µÉ ¼ö ÀÖµµ·Ï ¾ÈÀüÀåºñ¸¦ °®Ãß°í ÀÖ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¶ÇÇÑ Àç·á ¹× ¿£Áö´Ï¾î¸µÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ÀÀ±Þ »óȲ¿¡¼­ °¡È¤ÇÑ »ç¿ë¿¡µµ °ßµô ¼ö ÀÖ´Â ´õ ưưÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ±â±â°¡ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ¸·Î °ñ¼ö³» ÁÖÀÔÀº ´õ ¸¹Àº ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾úÀ¸¸ç, º´¿ø Àü, º´¿ø ¹× ±º ȯ°æ¿¡¼­ »ç¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

°ñ¼ö³» ÁÖÀÔ ±â±â¿¡ ´ëÇÑ ÇコÄɾî ÇöÀå ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

ÁßȯÀÚ Ä¡·á¿¡¼­ °ñ¼ö³» ÁÖÀÔ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÇ·á Á¾»çÀÚ ±³À° ÇÁ·Î±×·¥ÀÌ È®´ëµÊ¿¡ µû¶ó ÀÇ·á°è Àü¹Ý¿¡¼­ °ñ¼ö³» ÁÖÀÔ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±¸±Þ´ë¿ø, ±¸±Þ´ë¿ø, ±ºÀǰü µî ´õ ¸¹Àº ÀÇ·áÁøÀÌ º¹°­³» Àåºñ »ç¿ë¿¡ ´ëÇÑ ±³À°À» ¹Þ°í ÀÖÀ¸¹Ç·Î ÀÌ ±â±âÀÇ Ã¤ÅÃÀÌ ´õ¿í È®»êµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ±â±â´Â ÀÀ±Þ½ÇÀ̳ª ÁßÁõ ȯÀÚ ÀÌ¼Û Áß°ú °°ÀÌ ¼øÈ¯°è·ÎÀÇ ºü¸¥ Á¢±ÙÀÌ ÇʼöÀûÀÎ »óȲ¿¡¼­ ƯÈ÷ À¯¿ëÇÏ°Ô »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ç÷°ü ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ´Â ¸¸¼ºÁúȯ ¹× ÁúȯÀÇ È®»êÀ¸·Î ÀÎÇØ ´ëü Ç÷°ü Á¢±Ù¹ýÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö¸é¼­ °ñ¼ö³» ÁÖÀÔ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåºñÀÇ Ã¤ÅÃÀº ƯÁ¤ ÀÀ±Þ »óȲ¿¡¼­ »ç¿ëÀ» ±ÇÀåÇÏ´Â ÃֽŠÀÓ»ó Áöħ°ú ÇÁ·ÎÅäÄÝ¿¡ ÀÇÇØ Áö¿øµÇ°í ÀÖÀ¸¸ç, Çö´ë ÀÇ·á ÇöÀå¿¡¼­ÀÇ ¿ªÇÒÀÌ °­È­µÇ°í ÀÖ½À´Ï´Ù.

°ñ¼ö³» ÁÖÀÔ ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

°ñ¼ö³» ÁÖÀÔ ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü, ¿ëµµ È®´ë ¹× ÁßȯÀÚ Ä¡·á¿¡¼­ ½Å¼ÓÇÑ Ç÷°ü Á¢±Ù¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡¿Í ¹ÐÁ¢ÇÑ °ü·ÃÀÌ ÀÖ´Â ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â Àåºñ ¼³°èÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ º¹°­³» ÁÖÀÔÀÌ ´õ ½±°í, ´õ ¾ÈÀüÇϰí, ´õ ½Å·ÚÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·Î ÀÎÇØ ÀÀ±Þ½Ç, ÁßȯÀÚ½Ç, º´¿ø Àü Áø·á µî ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ äÅÃÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿Ü»ó, ½ÉÀå ÀÀ±Þ »óȲ ¹× Áï°¢ÀûÀÎ Ç÷°ü Á¢±ÙÀÌ ÇÊ¿äÇÑ ±âŸ ÁúȯÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ±âÁ¸ÀÇ Á¤¸Æ Á¢±ÙÀÌ ¾î·Á¿î °æ¿ì ºü¸£°í È¿°úÀûÀÎ ´ë¾ÈÀ» Á¦°øÇϹǷΠ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÀ±Þ»óȲ¿¡¼­ ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ´Â µ¥ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÇ·á Àü¹®°¡¸¦ À§ÇÑ ±³À°ÀÌ Á¡Á¡ ´õ ¸¹ÀÌ Á¦°øµÇ°í ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼¿¡ µû¶ó °ñ¼ö³» ÁÖÀÔ ±â±â ½ÃÀåÀº ÷´ÜÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ½Å¼ÓÇÑ Ç÷°ü Á¢±Ù ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÁßȯÀÚ Ä¡·á ÇöÀåÀÇ ¿ä±¸¿¡ ÈûÀÔ¾î Áö¼ÓÀûÀÎ ¼ºÀåÀÌ ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÃÑ 42°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Intraosseous Infusion Devices Market to Reach US$8.2 Billion by 2030

The global market for Intraosseous Infusion Devices estimated at US$5.4 Billion in the year 2023, is expected to reach US$8.2 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Automatic Technology, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$5.6 Billion by the end of the analysis period. Growth in the Manual Technology segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 5.8% CAGR

The Intraosseous Infusion Devices market in the U.S. is estimated at US$1.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 5.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.1% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Intraosseous Infusion Devices Market - Key Trends & Drivers Summarized

What Are Intraosseous Infusion Devices and Why Are They Critical in Emergency Medical Care?

Intraosseous infusion devices are specialized medical tools designed to deliver fluids, medications, and blood products directly into the bone marrow when traditional intravenous (IV) access is not feasible. These devices are critical in emergency medical care, particularly in situations where time is of the essence, such as during trauma, cardiac arrest, or shock, where patients may have collapsed veins or other conditions that make IV access difficult. Intraosseous infusion provides a rapid, reliable, and effective alternative for vascular access, ensuring that lifesaving treatments can be administered quickly. The use of these devices is growing, especially in emergency rooms, intensive care units, and military settings, where immediate vascular access can significantly impact patient outcomes.

How Are Technological Advancements Shaping the Intraosseous Infusion Devices Market?

Technological advancements are playing a significant role in shaping the intraosseous infusion devices market, particularly through innovations in device design, ease of use, and safety features. Modern intraosseous devices are increasingly being designed for automatic or semi-automatic deployment, which reduces the skill level required for insertion and minimizes the risk of complications. These devices now often feature safety mechanisms to prevent needle-stick injuries and to ensure secure placement within the bone marrow. Additionally, advancements in materials and engineering have led to the development of more durable and reliable devices that can withstand the rigors of emergency use. These innovations are making intraosseous infusion more accessible to a broader range of healthcare providers, thereby expanding its use in pre-hospital, hospital, and military environments.

Why Is There an Increasing Demand for Intraosseous Infusion Devices Across Healthcare Settings?

The demand for intraosseous infusion devices is increasing across healthcare settings due to the growing recognition of their effectiveness in critical care situations and the expanding training programs for healthcare professionals. As more healthcare providers, including paramedics, emergency physicians, and military medics, are trained in the use of intraosseous devices, their adoption is becoming more widespread. The devices are particularly valued in settings where rapid access to the circulatory system is essential, such as in emergency rooms and during transport of critically ill patients. Additionally, the increasing prevalence of chronic diseases and conditions that can lead to vascular complications is driving the need for alternative vascular access methods, further boosting demand for intraosseous infusion devices. The adoption of these devices is also supported by updated clinical guidelines and protocols that recommend their use in specific emergency situations, reinforcing their role in modern medical practice.

What Factors Are Driving the Growth in the Intraosseous Infusion Devices Market?

The growth in the intraosseous infusion devices market is driven by several factors closely tied to technological advancements, expanding applications, and the increasing need for rapid vascular access in critical care. One of the primary drivers is the advancement in device design, which has made intraosseous infusion easier to perform, safer, and more reliable. This has led to broader adoption across various healthcare settings, including emergency departments, intensive care units, and pre-hospital care. The rising incidence of trauma, cardiac emergencies, and other conditions requiring immediate vascular access is also fueling market growth, as these devices offer a fast and effective alternative when traditional IV access is challenging. Additionally, the growing focus on improving patient outcomes in emergency situations, along with the increasing availability of training for healthcare professionals, is driving the market forward. As these trends continue to evolve, the intraosseous infusion devices market is expected to experience sustained growth, driven by the need for advanced, reliable, and rapid vascular access solutions in critical care scenarios.

Select Competitors (Total 42 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â